You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

lenvatinib

( len VA ti nib )
Funding:
Exceptional Access Program
  • lenvatinib - For the treatment of patients with locally recurrent or metastatic, progressive, radioactive-iodine-refractory differentiated thyroid cancer (DTC) according to criteria
  • lenvatinib - For the treatment of unresectable advanced hepatocellular carcinoma according to clinical criteria
Other Name(s): Lenvima®
Appearance: capsule in various strengths, shapes and colours

You might also be interested in